Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 24, 2008

Drug Name Review Type Class Manufacturer
Patanase New Drug Initial Review Nasal Preparations � Other Alcon
Requip XL New Drug Initial Review Antiparkinson Agents GlaxoSmithKline
Bystolic New Drug Initial Review Beta Blocker Forest
Evamist New Drug Initial Review Hormone Replacement Therapy Ther-Rx
Zamicet New Drug Initial Review Narcotics Hawthorne
Treximet New Drug Appeal Triptans � Combination GlaxoSmithKline
Cimzia New Drug Appeal Biologic Response Modifiers UCB
Suprax Susp PDL Appeal Antibiotics � Cephalosporins Lupin
Symbicort PDL Appeal Inhaled Steroids AstraZeneca
Baraclude PDL Appeal Hepatitis B Agents Bristol-Myers Squibb
Vytorin PDL Appeal Statin Combination Merck Schering Plough